Understanding Your Diagnosis
At a Glance
Bullous Pemphigoid is a non-contagious, treatable autoimmune skin condition primarily affecting adults over 70. It happens when the immune system mistakenly attacks the microscopic anchors holding skin layers together, causing fluid-filled blisters that can be treated with medication.
Receiving a diagnosis of Bullous Pemphigoid (BP) can feel overwhelming, especially when you see blisters appearing on your skin. It is natural to feel concerned, but understanding the nature of this condition is the first step toward managing it effectively. This page is designed to help you get your bearings, understand what is happening inside your body, and provide peace of mind as you begin your treatment journey.
Three Stabilizing Facts
When you are first diagnosed, it is helpful to focus on these three core truths about the condition:
- It is not contagious. You cannot “catch” Bullous Pemphigoid from someone else, and you cannot give it to others through touch, hugging, or sharing items [1][2]. It is an internal issue caused by your own immune system, not by germs, viruses, or bacteria [3].
- It is a well-recognized condition. While it may be new to you, BP is the most common autoimmune blistering disease [4][1]. Doctors who specialize in skin (dermatologists) see this condition frequently and have established protocols for treating it [5].
- Effective treatments are available. There are highly successful ways to control the blisters and the itching. While management can be complex due to other health factors, modern medicine offers various options—from creams to pills—to help your skin heal [6][7].
Who Does This Affect?
Bullous Pemphigoid primarily affects the elderly, with most cases occurring in people over the age of 70 [4][1]. It does not seem to prefer any specific race, ethnicity, or geographic location [8][9]. While we don’t always know exactly why it starts, it is sometimes linked to certain neurological conditions like dementia or stroke, or even specific medications used to treat diabetes [10][4].
What is Happening to My Skin?
To understand BP, it helps to think of your skin as a two-story house. The top floor is the epidermis (the surface you see), and the bottom floor is the dermis (the deeper layer).
In healthy skin, these two “floors” are held together by microscopic “anchors” called hemidesmosomes [1][2]. These anchors are made of specific proteins (specifically BP180 and BP230) that act like glue [11].
In Bullous Pemphigoid, your immune system—which is supposed to fight off infections—mistakenly creates autoantibodies (proteins that attack your own body) [1]. These autoantibodies target those “anchors” [12]. When the anchors are attacked:
- The glue holding the skin layers together fails.
- The top layer of skin separates from the bottom layer.
- Fluid rushes into the space created by the separation, forming a bulla (the medical term for a large blister) [1][12].
For more details on how this process works, visit The Science of Skin Separation.
Moving Forward
The goal of treatment is to stop the immune system’s attack on these skin anchors so your skin can heal. Because the immune system is involved, this is considered an autoimmune condition [1]. Your medical team will focus on reducing inflammation and preventing new blisters from forming, usually starting with medications like corticosteroids [13][7]. While the road to recovery requires patience, the vast majority of patients find relief and significant skin improvement with the right care plan [6].
Common questions in this guide
Is Bullous Pemphigoid contagious?
Why are blisters forming on my skin?
Who is most likely to get Bullous Pemphigoid?
Are there effective treatments for Bullous Pemphigoid?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What specific evidence from my biopsy or blood tests confirms this is Bullous Pemphigoid rather than another blistering condition?
- 2.Given my other health conditions and medications, what is the safest first-line treatment for me?
- 3.What is the goal of our treatment plan—is it complete clearance of blisters or manageable symptom control?
- 4.What are the 'steroid-sparing' options available to me if I cannot tolerate long-term prednisone?
- 5.How will we monitor for side effects of my treatment, especially since I am in an older age group?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (13)
- 1
Serum autoantibody reactivity in bullous pemphigoid is associated with neuropsychiatric disorders and the use of antidiabetics and antipsychotics: a large, prospective cohort study.
Dikmen HO, Yilmaz K, Benoit S, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV 2022; (36(11)):2181-2189 doi:10.1111/jdv.18414.
PMID: 35796163 - 2
Evidence for a role of eosinophils in blister formation in bullous pemphigoid.
de Graauw E, Sitaru C, Horn M, et al.
Allergy 2017; (72(7)):1105-1113 doi:10.1111/all.13131.
PMID: 28135772 - 3
IgE autoreactivity in bullous pemphigoid: eosinophils and mast cells as major targets of pathogenic immune reactants.
Freire PC, Muñoz CH, Stingl G
The British journal of dermatology 2017; (177(6)):1644-1653 doi:10.1111/bjd.15924.
PMID: 28868796 - 4
Neurological disorders are associated with bullous pemphigoid.
Papakonstantinou E, Limberg MM, Gehring M, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV 2019; (33(5)):925-929 doi:10.1111/jdv.15444.
PMID: 30663128 - 5
T regulatory cells and other lymphocyte subsets in patients with bullous pemphigoid.
Gambichler T, Tsitlakidon A, Skrygan M, et al.
Clinical and experimental dermatology 2017; (42(6)):632-637 doi:10.1111/ced.13135.
PMID: 28590036 - 6
Can Methotrexate Be Employed as Monotherapy for Bullous Pemphigoid? Analysis of Efficiency and Tolerance of Methotrexate Treatment in Patients with Bullous Pemphigoid.
Wojtczak M, Nolbrzak A, Woźniacka A, Żebrowska A
Journal of clinical medicine 2023; (12(4)) doi:10.3390/jcm12041638.
PMID: 36836172 - 7
Adjuvant treatment of severe/refractory bullous pemphigoid with protein A immunoadsorption.
Hübner F, Kasperkiewicz M, Knuth-Rehr D, et al.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2018; (16(9)):1109-1118 doi:10.1111/ddg.13642.
PMID: 30179319 - 8
Ethnic variations in the epidemiology of bullous pemphigoid in Israel.
Kridin K, Bergman R
International journal of dermatology 2018; (57(1)):34-39 doi:10.1111/ijd.13813.
PMID: 29090462 - 9
Bullous pemphigoid and renal graft rejection: is there a causative link?
Sartor E, Sernicola A, Silvestre C, et al.
European journal of dermatology : EJD 2020; (30(4)):441-442 doi:10.1684/ejd.2020.3837.
PMID: 32815815 - 10
The global incidence of bullous pemphigoid: a systematic review and meta-analysis.
Persson MSM, Begum N, Grainge MJ, et al.
The British journal of dermatology 2022; (186(3)):414-425 doi:10.1111/bjd.20743.
PMID: 34480482 - 11
Bullous pemphigoid.
Bağcı IS, Horváth ON, Ruzicka T, Sárdy M
Autoimmunity reviews 2017; (16(5)):445-455 doi:10.1016/j.autrev.2017.03.010.
PMID: 28286109 - 12
From Molecular Insights to Clinical Perspectives in Drug-Associated Bullous Pemphigoid.
de Nicolas-Ruanes B, Ballester-Martinez A, Garcia-Mouronte E, et al.
International journal of molecular sciences 2023; (24(23)) doi:10.3390/ijms242316786.
PMID: 38069109 - 13
An open, multicentre, randomized clinical study in patients with bullous pemphigoid comparing methylprednisolone and azathioprine with methylprednisolone and dapsone.
Sticherling M, Franke A, Aberer E, et al.
The British journal of dermatology 2017; (177(5)):1299-1305 doi:10.1111/bjd.15649.
PMID: 28494097
This page provides an educational overview of Bullous Pemphigoid. It is for informational purposes only and should not replace professional medical advice, diagnosis, or treatment from your dermatologist.
Get notified when new evidence is published on Bullous pemphigoid.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.